查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2008353

经经皮肾镜取石术市场：依产品类型、手术类型、结石类型、入路、病患类型、应用和最终用户划分－2026-2032年全球市场预测

Percutaneous Nephrolithotomy Market by Product Type, Procedure Type, Stone Type, Access Approach, Patient Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，经皮肾镜取石术市场价值为 8.1377 亿美元，到 2026 年成长至 8.783 亿美元，到 2032 年达到 14.2829 亿美元，年复合成长率为 8.36%。

主要市场统计数据
基准年 2025 8.1377亿美元
预计年份：2026年 8.783亿美元
预测年份 2032 1,428,290,000 美元
复合年增长率 (%) 8.36%

一个清晰的临床和商业性框架，将不断发展的外科手术实践、医疗设备创新和经皮肾镜取石术。

经皮肾镜取石术)仍然是体外震波碎石术 (ESW) 或纯内视镜治疗无法处理的临床显着肾结石的基石治疗方法。临床医生、医院管理者和医疗设备製造商正努力应对这样一个环境：手术方案的选择受到病患合併症、结石复杂程度以及器械和影像技术进步的影响。在实践中，这意味着入路系统、肾镜、碎石平台以及辅助引流和闭塞装置必须整合到医疗机构的工作流程中，同时满足日益严格的安全性和效率要求。在整个医疗过程中，人们强烈希望最大限度地减少辐射暴露、减少泌尿道出血，并在不移除结石或损害长期肾功能的前提下缩短住院时间。这些临床需求，加上对一次性医疗设备日益增长的需求、门诊服务的扩展以及数位导航技术的普及，正在重塑所有相关人员的采购、培训和伙伴关係策略。

小型化、影像技术和机器人辅助导航的结合正在迅速改变肾结石治疗的设备设计、临床实践和机构工作流程。

经经皮肾镜取石术领域正经历一场融合式变革，涵盖器械小型化、手术流程优化、数位导航以及治疗部位的转变。从微型、超微型、微型到改良的标准方法，各种小型化通路策略均得到共识指南和随机对照试验数据的支持，这些数据表明，这些策略在降低出血併发症和输血风险的同时，还能在多种结石负荷下保持相当的结石清除率。这些临床数据推动了对更小尺寸肾镜、专用扩张器和细鞘套以及针对低位入路优化的取石平台的需求。同时，影像和导航技术正透过超音波引导、扩增实境（AR）规划和机器人辅助针头引导系统，减少对透视的依赖。早期可行性研究和临床病例係列研究表明，这些技术可以提高首次穿刺成功率，并减少患者和医务人员的辐射暴露。虽然机器人辅助和导航系统尚未普及，但在专注于高频复杂碎石治疗计画和学术培训计画的机构中，其应用正在不断增加，这加速了功能和特性方面的竞争，并改变了製造商优先考虑整合和支援外科医生的方式。

美洲、欧洲、中东和非洲以及亚太地区的区域差异正在决定采购重点、监管途径和部署速度。

区域趋势对监管路径、采购偏好和临床工作流程有显着影响，而这些对于产品设计和商业策略至关重要。在美洲，医院整合、大规模综合医生集团以及完善的门诊手术中心生态系统正在形成高流量区域，标准化耗材包和可预测的服务合约能够在这些区域获得市场份额。支付结构和合约实务强调能够提高处理能力、缩短住院时间并与现有无菌或一次性使用策略整合的医疗设备。欧洲、中东和非洲 (EMEA) 地区是一个多元化的市场，其影响因素包括各国特定的采购结构、对卫生技术评估 (HTA) 的更高重视程度以及国内生产能力的差异。因此，供应商必须调整监管文件、本地服务结构和性价比策略才能成功。在许多 EMEA 市场，感染控制和采购透明度是推动一次性产品普及的重要因素，而环境和循环经济的考量也日益影响竞标评估。亚太地区在三级医疗机构中迅速采用先进的影像和导航技术，拥有强大的原始设备製造商 (OEM) 和零件供应基础，以及多样化的报销模式。确保这些技术在这些市场的可持续应用通常需要与当地契约製造建立合作关係，并建立有针对性的临床证据。了解这些区域差异（例如人员技能、细緻的报销方案和当地供应商生态系统）对实际应用的影响，有助于企业制定差异化的监管应对措施、临床证据和商业性投资方案，以适应当地的优先事项和风险接受度。当临床证据和模组化平台与稳健的供应链和服务主导的部署策略结合时，企业便能获得竞争优势。

领导者应优先采取实际有效的措施，使产品蓝图、供应链和服务模式与不断变化的临床和商业性需求保持一致。

产业领导者应在多个领域采取果断行动，以确保先进经皮肾镜取石术技术的普及应用、维持获利能力并加速永续推广。首先，他们应使产品蓝图与临床对更小巧、更安全入路的需求保持一致。应优先开发低轮廓肾镜、通道系统和灌注/抽吸解决方案，以在保持疗效的同时减少组织损伤。其次，他们应投资于成像和导航的互通性，使系统能够与现有的透视、超音波设备和新兴的3D规划生态系统连接。开放的介面和临床整合将减少采购摩擦并缩短部署时间。第三，他们应重新考虑全球采购和组装地点，以降低关税风险和零件短缺的影响。在更靠近市场的组装、关键光学和半导体组件的双重采购以及透明的供应商可追溯性对于缩短前置作业时间和维持盈利能力至关重要。第四，我们将建立一个服务包，结合外科培训、远距教学和耗材定价模式，专为高吞吐量的门诊环境而设计，在这些环境中，可预测的病例成本至关重要。最后，我们将把环境因素纳入一次性产品策略，试行推行回收和产品召回计划，并向采购委员会透明地传达产品生命週期影响。解决这些优先事项不仅可以缓解贸易政策变化带来的短期不利影响，还能为各机构在治疗模式和医疗场所选择不断变化的情况下获得可持续的竞争优势奠定基础。

透明的调查方法，说明了临床证据的整合、贸易政策审查、与主要相关人员的访谈以及交叉检验的技术和商业性实质审查。

本分析所依据的研究整合了同侪审查的临床文献、对政策和监管公告的系统性回顾、对采购和临床负责人的访谈，以及对产品系列和供应链的技术实质审查。临床证据的整合利用了系统综述、共识声明和前瞻性可行性研究，以描述微型经皮肾镜取石术（PCNL）技术和影像引导入路系统的安全性、相对疗效和应用障碍。透过仔细审查政府公告和主要贸易机构的最新报告，评估了贸易和政策的影响，以了解关税设计、豁免以及对医疗设备供应链的潜在营运影响。市场和企业分析结合了公开文件、监管核准记录以及对选定的医疗设备製造商和高运作机构的直接访谈，以评估产品定位、服​​务模式和商业策略。在可能的情况下，交叉引用多个资料来源以检验关键结论，并透过与临床医生和供应链负责人的访谈来检验研究结果，以确保其与实际决策的相关性和准确性。

我们将临床发展动能、关税导致的采购趋势变化以及策略需求连结起来，并将它们整合到一个连贯的相关人员。

总而言之，经经皮肾镜取石术的实践和商业性基础正在经历变革时期。临床上，人们越来越倾向于采用较小的入路和影像引导技术，这推动了对专用低轮廓器械、高清成像和可互通导航的需求。同时，机器人技术和基于扩增实境（AR）的规划工具正在重塑入路品质和培训的模式。此外，2025年的关税措施也凸显了供应链策略、双源采购和市场邻近组装的重要性，这些措施对于保护利润率和确保关键零件的供应至关重要。终端使用者越来越关注能够减少病例间差异、支持当日治疗路径并最大限度减少术后併发症的医疗设备和服务模式。对于製造商和医疗服务体係而言，成功需要协调投资于商业性创新性的服务产品，这些产品必须符合临床证据、强大的製造能力以及现代医疗服务中对手术经济性和环境影响的预期。以上具体建议可作为领导者的蓝图，帮助他们将这些见解转化为合理的短期选择，从而维持病患就医途径并支持组织绩效。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：经皮肾镜取石术市场：依产品类型划分

  • 访问系统
    • 针
    • 导管导引线
    • 扩充器
    • 鞘套
  • 破碎机
    • 超音波碎石机
    • 气动破碎机
  • 引流及闭塞装置
    • 输尿管支架
    • 肾造瘻管
    • 闭合装置
  • 肾镜
    • 柔性肾镜
    • 硬式肾镜
    • 数位肾镜
  • 医学影像和导航系统
    • X射线系统
    • 三维导航机器人系统
    • 超音波引导系统
  • 一次性产品和配件
    • 吸力装置
    • 清洁系统
    • 收集篮

第九章经皮肾镜取石术术市场（依手术类型划分）

  • 微
  • 小型的
  • 标准
  • 超迷你

第十章：经皮肾镜取石术市场（依结石类型划分）

  • 草酸钙结石
  • 尿酸结石
  • 鸟粪石
  • 胱氨酸结石

第十一章经皮肾镜取石术市场进入方法

  • 俯卧进阶
  • 仰卧位
  • 侧卧入路

第十二章 依病患类型分類的经皮肾镜取石术市场

  • 成人版
  • 老年人
  • 儿童

第十三章：经皮肾镜取石术市场：依应用领域划分

  • 肾结石
  • 鹿角石

第十四章：经皮肾镜取石术市场：依最终用户划分

  • 门诊手术中心
  • 医院
  • 泌尿系统诊所
  • 学术和研究机构

第十五章：经皮肾镜取石术市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章：经皮肾镜取石术市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章经皮肾镜取石术市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国经皮肾镜取石术市场

第十九章：中国经皮肾镜取石术市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Advin Urology
  • Allengers Medical Systems Ltd.
  • Biorad Medisys Pvt Ltd.
  • Blue Neem Medical Devices Private Limited
  • Boen Healthcare Co., Ltd.
  • Boston Scientific Corporation
  • Coloplast Corporation
  • Cook Group Incorporated
  • Dornier MedTech
  • EMS Electro Medical Systems SA
  • EDAP TMS SA
  • ELMED INC.
  • Envaste Limited
  • Fore River Urology.
  • Manish Medi Innovation
  • Medispec Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Rocamed
  • Teleflex Incorporated
Product Code: MRR-C002B1C99560

The Percutaneous Nephrolithotomy Market was valued at USD 813.77 million in 2025 and is projected to grow to USD 878.30 million in 2026, with a CAGR of 8.36%, reaching USD 1,428.29 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 813.77 million
Estimated Year [2026] USD 878.30 million
Forecast Year [2032] USD 1,428.29 million
CAGR (%) 8.36%

A clear clinical and commercial framing that links evolving procedural practice, device innovation, and healthcare delivery priorities for percutaneous nephrolithotomy

Percutaneous nephrolithotomy remains a cornerstone intervention for clinically significant renal calculi that are not amenable to shockwave or purely endoscopic therapy. Clinicians, hospital administrators, and device manufacturers are navigating an environment where procedural choices are shaped by patient comorbidity, stone complexity, and the evolving technical capabilities of instruments and imaging. In practice, this means that access systems, nephroscopes, lithotripsy platforms, and adjunctive drainage and closure devices must integrate with facility workflows while meeting increasingly strict safety and efficiency expectations. Across the care continuum, there is strong emphasis on minimizing radiation exposure, reducing tract-related bleeding, and shortening length of stay without compromising stone clearance or long-term renal function. These clinical imperatives, together with rising demand for single-use disposables, expanded outpatient capabilities, and digitally enabled navigation, are reshaping procurement, training, and partnership strategies for all stakeholders.

Framing the market through this clinical lens highlights several immediate priorities: supporting surgeon training in miniaturized and image-guided techniques, ensuring supply chain robustness for critical consumables and components, and aligning product development with facility-level goals for throughput and value-based reimbursement. The following summary synthesizes the transformative shifts now underway, the specific implications of recent United States tariff actions in 2025, segmentation-level insights that inform product and go-to-market choices, regional differentiation, and pragmatic recommendations leaders can use to protect margins, preserve access, and accelerate responsible innovation.

Converging forces of miniaturization, imaging and robot-assisted navigation are rapidly reshaping device design, clinical practice, and facility workflows for kidney stone interventions

The landscape for percutaneous nephrolithotomy is undergoing convergent transformations that span device miniaturization, procedural technique, digital navigation, and care-site migration. Miniaturized tract strategies-spanning micro, ultra-mini, mini and modified standard approaches-have been supported by consensus guidance and randomized data demonstrating comparable stone-free outcomes for many stone burdens while reducing hemorrhagic complications and transfusion risk. These clinical data have in turn catalyzed demand for smaller nephroscopes, specialized dilators and thin sheaths, and lithotripter platforms optimized for low-profile access. Concurrently, imaging and navigation technologies are reducing dependence on fluoroscopy through ultrasound guidance, augmented reality planning, and robot-assisted needle targeting systems; early feasibility and clinical series show these technologies can improve first-pass access rates and reduce radiation exposure for patients and staff. Robotic and navigated systems are not yet ubiquitous, but they are increasingly adopted at centers focused on high-volume complex stone programs and academic training pathways, accelerating a competence-and-capability arms race that changes how manufacturers prioritize integration and surgeon support.

On the disposables front, single-use endoscopes, digital nephroscopes and disposable accessory portfolios are now a major strategic axis. These devices address infection control, reduce repair-related downtime, and simplify inventory management for high-throughput units, even as purchasers weigh environmental impact and unit economics. Finally, delivery-site migration toward higher-acuity ambulatory surgical centers and same-day care models is pressuring device makers to re-think portability, footprint, and service bundles so instruments can enable rapid turnover and predictable perioperative pathways. When taken together, these trends create a market that rewards modular platforms, interoperable imaging solutions, and manufacturer services that reduce the total cost and complexity of adoption while enabling rapid clinician learning curves and predictable patient outcomes. Evidence supporting miniaturization and image-guided techniques is consolidated in contemporary consensus statements and systematic reviews that are driving purchasing committees and clinical leaders to reassess legacy equipment portfolios and training investments; this is changing the timelines and priorities for product roadmaps across the ecosystem. How the 2025 United States tariff actions are creating immediate procurement pressure, supply chain reconfiguration, and strategic re-shoring incentives across device value chains

The tariff environment instituted in 2025 has introduced a new layer of commercial complexity for medical device sourcing, cost structures, and supplier selection. Official actions and policy modifications by trade authorities have translated into increased duties on a broad set of imported goods, and targeted adjustments to rates for specific product categories have been signaled through government releases and subsequent reporting. For suppliers that rely on cross-border manufacturing of precision components, optics, imaging subsystems, and semiconductor-containing controls, these duties materially raise landed costs and can lengthen procurement lead times while prompting immediate reassessments of near-term pricing and supplier contracts. In response, many health systems and physician groups face the choice of absorbing higher consumable prices, prioritizing domestic-sourced lines where available, or passing incremental cost through to purchasers where contracting levers allow.

Beyond direct price pressure, tariffs also accelerate strategic behaviors that change the competitive landscape. Manufacturers dependent on global contract manufacturing and just-in-time component supply face margin compression and potential product reengineering choices to substitute tariff-exposed components. Regulatory-driven exemptions and sector carve-outs have been applied in some instances, but the overall policy trajectory has incentivized re-shoring of critical production steps, diversification of supplier networks, and near-market final assembly for key imaging and navigation modules. Observers in the trade and healthcare sectors have documented the practical effects on both equipment categories and IT-dependent subsystems, noting acute sensitivity where semiconductor and high-precision electronics are integral to lithotripsy consoles, imaging suites and robotic controllers. Official trade documents and investigative reporting confirm that these policy changes are active and consequential for capital equipment and consumable procurement in 2025, prompting procurement teams to refresh total-cost-of-ownership models and contingency sourcing plans. A segmentation-led synthesis that links product architecture, procedural approach, patient phenotype, and end-user setting to commercial and clinical decision levers

Examining the market through carefully defined segmentation clarifies where clinical needs, procurement priorities, and technology opportunities intersect. When product type is used as the organizing principle, access systems-comprised of needles, guidewires, dilators, and sheaths-remain the procedural foundation because reliable, low-trauma access determines safety and the ability to complete stone clearance in a single session. Lithotripters split into ultrasonic and pneumatic approaches, each carrying different capital and consumable trade-offs and therefore appealing to different procedural mixes and facility economics. Drainage and closure devices, an essential adjunct to percutaneous practice, encompass ureteral stents, nephrostomy tubes, and sealing devices that influence recovery pathways and post-procedural morbidity. Nephroscopes now span flexible, rigid, and digital platforms with variable roles across micro, mini, and standard tract approaches, while imaging and navigation systems cover fluoroscopy, ultrasound-guided systems, and emerging 3D navigation and robotic-assist modalities that shape access quality. Disposables and accessories including suction devices, irrigation systems, and retrieval baskets form a high-turnover consumable layer that drives recurring revenue and inventory optimization concerns for providers.

Viewed by procedure type, micro, mini, standard and ultra-mini approaches each map onto different instrument sets and perioperative protocols; ultra-mini techniques require specialized low-profile optics and very fine sheaths, whereas standard procedures continue to rely on more robust channels and high-capacity lithotripsy. Stone type-such as calcium oxalate, uric acid, struvite, and cystine stones-determines fragmentation strategy and device wear characteristics, influencing consumable choice and energy delivery preferences. Access approach, whether prone, supine or lateral, influences OR setup, imaging orientation, and device ergonomics, and so product designers must appreciate working angles and sheath handling across patient positioning. Patient type-adult, geriatric and pediatric-requires differentiated sizing, anesthesia planning and post-operative pathway design, and application distinctions such as renal calculi versus complex staghorn calculi drive the need for multi-tract planning, combined techniques, or staged approaches. Finally, end users-ambulatory surgical centers, hospitals, specialty urology clinics and academic and research institutes-each exhibit distinct purchasing thresholds, service expectations, and training capacities that should inform go-to-market segmentation and support models. Integrating these segmentation lenses helps manufacturers prioritize modularity, inventoried consumables, and clinician education investments to maximize procedural fit and shorten time-to-adoption.

Regional differentiation across Americas, Europe Middle East & Africa, and Asia-Pacific determines procurement priorities, regulatory pathways, and adoption pacing

Regional dynamics exert distinct influences on regulatory pathways, procurement preferences and clinical workflows that matter for product design and commercial strategy. In the Americas, hospital consolidation, large integrated physician groups, and a robust ambulatory surgical center ecosystem create high-volume nodes where standardized consumable bundles and predictable service contracts can win share. Payment structures and contracting practices place a premium on devices that enable throughput, reduce length of stay and integrate with existing sterilization or single-use strategies. Europe, the Middle East and Africa present a heterogeneous mix where country-level procurement, stronger emphasis on health-technology assessment, and variable access to domestic manufacturing capacity mean that suppliers must adapt regulatory dossiers, local service footprints, and price-performance narratives to succeed. In many EMEA markets, infection control and procurement transparency are strong drivers of disposable adoption decisions, but environmental and circularity considerations increasingly influence tender evaluations. Asia-Pacific shows rapid adoption of advanced imaging and navigation in tertiary centers, an active OEM and component supply base, and a diverse set of reimbursement models; partnerships with regional contract manufacturers and targeted clinical evidence generation are often prerequisites for sustainable access across these markets. Understanding the practical implications of these regional differences-workforce skills, reimbursement nuance, and the local supplier ecosystem-enables companies to deploy differentiated regulatory, clinical evidence and commercial investments that fit local priorities and risk tolerances. Competitive advantage accrues to firms that pair clinical evidence and modular platforms with resilient supply chains and service-led adoption strategies

Company strategy in this space increasingly depends on the ability to combine clinical credibility, integrated service models, and modular technology platforms. Established manufacturers that supply access systems, lithotripters and imaging suites are balancing investment in next-generation, low-profile endoscopes and digital visualization with dealer and service channel optimization to protect installed base revenue. New entrants and smaller innovators are focusing on niche wins-novel sheath designs, low-cost ultrasound-guided access devices, disposable scope optics and software-enabled navigation-where rapid clinical evidence generation can create a pathway to inclusion in high-volume centers. Across both groups, partnerships with academic centers for human factors validation, multi-center registries, and real-world outcomes capture have become decisive differentiators at the tender and contract negotiation phases. Supply chain resilience, particularly for high-precision electronics and semiconductor-dependent subsystems, has emerged as a core competitive advantage; firms that can demonstrate multi-country sourcing and near-market assembly are better positioned to absorb tariff shocks and maintain supply continuity.

Service and support models are also evolving: companies that bundle training, simulation, and remote proctoring reduce the upfront friction associated with advanced navigation platforms and miniaturized techniques. Similarly, firms that co-design consumable pricing with high-use facilities to align per-case economics, introduce take-back or recycling programs for single-use devices, and offer flexible financing for capital equipment create compelling value propositions for procurement committees balancing cost, sustainability and clinical outcomes. These strategic choices-platform integration, evidence generation, supply chain transparency, and creative service models-will determine which companies move from vendor status to strategic partner in the emerging care pathways for kidney stone management.

Practical, high-impact actions leaders must prioritize to align product roadmaps, supply chains, and service models with evolving clinical and commercial demands

Industry leaders should act decisively on several fronts to preserve access, protect margins and accelerate sustainable adoption of advanced percutaneous nephrolithotomy technologies. First, align product roadmaps to the clinical imperative for smaller, safer access: prioritize development of lower-profile nephroscopes, tract systems and irrigation/suction solutions that reduce tissue trauma while maintaining efficacy. Second, invest in imaging and navigation interoperability so systems can plug into existing fluoroscopy, ultrasound and emerging 3D planning ecosystems; open interfaces and clinical integration reduce procurement friction and shorten onboarding timelines. Third, re-evaluate global sourcing and assembly footprints to mitigate tariff exposure and component scarcity; near-market assembly, dual-sourcing of key optics and semiconductor elements, and transparent supplier traceability will be essential to keep lead times short and margins intact. Fourth, construct service bundles that combine surgeon training, remote proctoring, and consumable pricing models designed for high-throughput ambulatory environments where predictable case cost matters most. Finally, incorporate environmental stewardship into disposable product strategies by piloting recycling or product take-back programs and communicating life-cycle impacts transparently to purchasing committees. Acting on these priorities will not only blunt short-term headwinds created by trade policy shifts, but will also position organizations to capture durable advantage as treatment patterns and care-site choices evolve.

Transparent methodology describing clinical evidence synthesis, trade-policy review, primary stakeholder interviews, and cross-validated technical and commercial diligence

The research underpinning this analysis integrates structured review of peer-reviewed clinical literature, policy and regulatory announcements, primary interviews with procurement and clinical leaders, and technical diligence on product portfolios and supply chains. Clinical evidence synthesis drew on systematic reviews, consensus statements and prospective feasibility studies to characterize procedural safety, comparative efficacy and adoption barriers across miniaturized PCNL techniques and image-guided access systems. Trade and policy impacts were assessed by reviewing government releases and contemporaneous reporting from primary trade authorities to understand tariff design, exemptions and likely operational impacts on medical device supply chains. Market and company analysis combined public filings, regulatory clearance records and primary outreach to selected device manufacturers and high-volume centers to evaluate product positioning, service models, and commercial tactics. Where possible, triangulation across multiple data sources was used to validate key assertions, and findings were stress-tested in interviews with clinicians and supply chain leaders to ensure practical relevance and fidelity to real-world decision-making.

Concluding synthesis that ties clinical momentum, tariff-induced procurement shifts, and strategic imperatives into a coherent action framework for stakeholders

In summary, the practice and commercial underpinnings of percutaneous nephrolithotomy are in transition. Clinical momentum toward miniaturized tracts and image-guided access is catalyzing demand for specialized low-profile instruments, high-fidelity imaging and interoperable navigation, while robotics and augmented planning tools are beginning to re-shape access quality and training paradigms. At the same time, the tariff actions in 2025 have heightened the importance of supply chain strategy, dual-sourcing, and near-market assembly as levers to protect margin and ensure availability of critical components. End users are increasingly focused on devices and service models that lower per-case variability, support same-day care pathways, and reduce downstream complications. For manufacturers and provider systems alike, success will require coordinated investment in clinical evidence, resilient manufacturing footprints, and commercially creative service offerings that align with the procedural economics and environmental expectations of modern healthcare delivery. The practical recommendations described above provide a roadmap for leaders to translate these insights into defensible, near-term choices that sustain patient access and institutional performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Percutaneous Nephrolithotomy Market, by Product Type

  • 8.1. Access Systems
    • 8.1.1. Needles
    • 8.1.2. Guidewires
    • 8.1.3. Dilators
    • 8.1.4. Sheaths
  • 8.2. Lithotripters
    • 8.2.1. Ultrasonic Lithotripters
    • 8.2.2. Pneumatic Lithotripters
  • 8.3. Drainage & Closure Devices
    • 8.3.1. Ureteral Stents
    • 8.3.2. Nephrostomy Tubes
    • 8.3.3. Sealing Devices
  • 8.4. Nephroscopes
    • 8.4.1. Flexible Nephroscopes
    • 8.4.2. Rigid Nephroscopes
    • 8.4.3. Digital Nephroscopes
  • 8.5. Imaging & Navigation Systems
    • 8.5.1. Fluoroscopy Systems
    • 8.5.2. 3D Navigation & Robotic Systems
    • 8.5.3. Ultrasound-Guided Systems
  • 8.6. Disposables & Accessories
    • 8.6.1. Suction Devices
    • 8.6.2. Irrigation Systems
    • 8.6.3. Retrieval Baskets

9. Percutaneous Nephrolithotomy Market, by Procedure Type

  • 9.1. Micro
  • 9.2. Mini
  • 9.3. Standard
  • 9.4. Ultra Mini

10. Percutaneous Nephrolithotomy Market, by Stone Type

  • 10.1. Calcium Oxalate Stones
  • 10.2. Uric Acid Stones
  • 10.3. Struvite Stones
  • 10.4. Cystine Stones

11. Percutaneous Nephrolithotomy Market, by Access Approach

  • 11.1. Prone Access
  • 11.2. Supine Access
  • 11.3. Lateral Access

12. Percutaneous Nephrolithotomy Market, by Patient Type

  • 12.1. Adult
  • 12.2. Geriatric
  • 12.3. Pediatric

13. Percutaneous Nephrolithotomy Market, by Application

  • 13.1. Renal Calculi
  • 13.2. Staghorn Calculi

14. Percutaneous Nephrolithotomy Market, by End User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Hospitals
  • 14.3. Specialty Urology Clinics
  • 14.4. Academic & Research Institutes

15. Percutaneous Nephrolithotomy Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Percutaneous Nephrolithotomy Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Percutaneous Nephrolithotomy Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Percutaneous Nephrolithotomy Market

19. China Percutaneous Nephrolithotomy Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Advin Urology
  • 20.6. Allengers Medical Systems Ltd.
  • 20.7. Biorad Medisys Pvt Ltd.
  • 20.8. Blue Neem Medical Devices Private Limited
  • 20.9. Boen Healthcare Co., Ltd.
  • 20.10. Boston Scientific Corporation
  • 20.11. Coloplast Corporation
  • 20.12. Cook Group Incorporated
  • 20.13. Dornier MedTech
  • 20.14. E.M.S. Electro Medical Systems S.A.
  • 20.15. EDAP TMS SA
  • 20.16. ELMED INC.
  • 20.17. Envaste Limited
  • 20.18. Fore River Urology.
  • 20.19. Manish Medi Innovation
  • 20.20. Medispec Ltd.
  • 20.21. Olympus Corporation
  • 20.22. Richard Wolf GmbH
  • 20.23. Rocamed
  • 20.24. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC LITHOTRIPTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC LITHOTRIPTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC LITHOTRIPTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC LITHOTRIPTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC LITHOTRIPTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC LITHOTRIPTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSTOMY TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSTOMY TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSTOMY TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SEALING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SEALING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SEALING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FLEXIBLE NEPHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FLEXIBLE NEPHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FLEXIBLE NEPHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RIGID NEPHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RIGID NEPHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RIGID NEPHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DIGITAL NEPHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DIGITAL NEPHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DIGITAL NEPHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FLUOROSCOPY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FLUOROSCOPY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FLUOROSCOPY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY 3D NAVIGATION & ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY 3D NAVIGATION & ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY 3D NAVIGATION & ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASOUND-GUIDED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASOUND-GUIDED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASOUND-GUIDED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUCTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUCTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUCTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IRRIGATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IRRIGATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IRRIGATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RETRIEVAL BASKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RETRIEVAL BASKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RETRIEVAL BASKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY CALCIUM OXALATE STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY CALCIUM OXALATE STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY CALCIUM OXALATE STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY URIC ACID STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY URIC ACID STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY URIC ACID STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STRUVITE STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STRUVITE STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STRUVITE STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY CYSTINE STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY CYSTINE STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY CYSTINE STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRONE ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRONE ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRONE ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUPINE ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUPINE ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUPINE ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LATERAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LATERAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LATERAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SPECIALTY UROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SPECIALTY UROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SPECIALTY UROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 278. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 279. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 280. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 281. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 282. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 283. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 286. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS,